Swiss National Bank Novo Cure LTD Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Novo Cure LTD stock. As of the latest transaction made, Swiss National Bank holds 199,600 shares of NVCR stock, worth $3.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

199,600

Previous 199,600 -0.0%

Holding current value

$3.54 Million

Previous $3.42 Million 8.77%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$11.13 - $15.78 $244,860 - $347,160	-22,000 Reduced 9.93%	199,600 $2.98 Million
Q3 2023 Nov 08, 2023	SELL	$16.15 - $42.35 $1.93 Million - $5.07 Million	-119,700 Reduced 35.07%	221,600 $3.58 Million
Q2 2023 Aug 09, 2023	SELL	$40.29 - $82.51 $1.31 Million - $2.69 Million	-32,600 Reduced 8.72%	341,300 $14.2 Million
Q1 2023 May 10, 2023	SELL	$56.44 - $118.81 $519,248 - $1.09 Million	-9,200 Reduced 2.4%	373,900 $22.5 Million
Q4 2022 Feb 08, 2023	SELL	$63.98 - $85.37 $1.53 Million - $2.04 Million	-23,948 Reduced 5.88%	383,100 $28.1 Million
Q3 2022 Nov 09, 2022	SELL	$67.99 - $89.57 $20,397 - $26,870	-300 Reduced 0.07%	407,048 $30.9 Million
Q2 2022 Aug 09, 2022	BUY	$56.6 - $89.9 $147,160 - $233,740	2,600 Added 0.64%	407,348 $28.3 Million
Q1 2022 May 09, 2022	BUY	$60.15 - $84.52 $3.03 Million - $4.25 Million	50,300 Added 14.19%	404,748 $33.5 Million
Q4 2021 Feb 08, 2022	SELL	$75.08 - $121.99 $1.02 Million - $1.66 Million	-13,600 Reduced 3.7%	354,448 $26.6 Million
Q3 2021 Nov 08, 2021	SELL	$116.17 - $194.55 $906,126 - $1.52 Million	-7,800 Reduced 2.08%	368,048 $42.8 Million
Q2 2021 Aug 06, 2021	BUY	$130.4 - $225.58 $5.61 Million - $9.71 Million	43,048 Added 12.94%	375,848 $83.4 Million
Q1 2021 May 07, 2021	BUY	$124.11 - $190.17 $1.03 Million - $1.58 Million	8,300 Added 2.56%	332,800 $44 Million
Q4 2020 Feb 05, 2021	BUY	$112.16 - $174.14 $14.7 Million - $22.8 Million	131,000 Added 67.7%	324,500 $56.2 Million
Q3 2020 Nov 09, 2020	BUY	$58.05 - $111.31 $255,420 - $489,764	4,400 Added 2.33%	193,500 $21.5 Million
Q2 2020 Aug 05, 2020	BUY	$57.2 - $74.41 $2.03 Million - $2.64 Million	35,500 Added 23.11%	189,100 $11.2 Million
Q1 2020 May 08, 2020	BUY	$57.05 - $95.75 $182,560 - $306,400	3,200 Added 2.13%	153,600 $10.3 Million
Q4 2019 Feb 06, 2020	BUY	$68.3 - $93.8 $423,460 - $581,560	6,200 Added 4.3%	150,400 $12.7 Million
Q3 2019 Nov 12, 2019	BUY	$61.86 - $97.8 $173,208 - $273,840	2,800 Added 1.98%	144,200 $10.8 Million
Q2 2019 Aug 02, 2019	BUY	$42.22 - $63.23 $958,394 - $1.44 Million	22,700 Added 19.12%	141,400 $8.94 Million
Q1 2019 May 10, 2019	BUY	$31.96 - $56.12 $134,232 - $235,704	4,200 Added 3.67%	118,700 $5.72 Million
Q4 2018 Feb 13, 2019	BUY	$28.72 - $52.63 $143,600 - $263,150	5,000 Added 4.57%	114,500 $3.83 Million
Q2 2018 Aug 09, 2018	BUY	$19.85 - $32.0 $637,185 - $1.03 Million	32,100 Added 41.47%	109,500 $3.43 Million
Q1 2018 May 04, 2018	BUY	$19.3 - $23.65 $71,410 - $87,505	3,700 Added 5.02%	77,400 $1.69 Million
Q3 2017 Nov 03, 2017	BUY	$18.05 - $21.75 $1.33 Million - $1.6 Million	73,700	73,700 $1.46 Million

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Novo Cure LTD Transaction History